Prestige BioPharma Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
So-Yeon Park
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 8.8yrs |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | 4.2yrs |
Recent management updates
Recent updates
CEO
So-Yeon Park (60 yo)
8.8yrs
Tenure
Ms. So-yeon Park is Chairman and CEO at Prestige BioPharma Limited and has been its director since July 13, 2015.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & CEO | 8.8yrs | no data | no data | |
CFO & Director | 4yrs | no data | no data | |
COO & Director | 7.4yrs | no data | no data | |
Independent Director | 4.3yrs | no data | no data | |
Independent Director | 4.3yrs | no data | no data | |
Independent Director | 4.1yrs | no data | no data | |
Independent Director | 4.1yrs | no data | no data | |
Independent Director | 4.1yrs | no data | no data |
4.2yrs
Average Tenure
59.5yo
Average Age
Experienced Board: A950210's board of directors are considered experienced (4.2 years average tenure).